pharma news today glp-1 today Giants Bet on Next-Generation Treatments to Sustain Growth As GLP-1 drugs for obesity
Description
In our recent webinar moderated by Lydia Ramsey Pflanzer of Endpoints News, David Burdick, Sarah Thompson, and Heidi Guetzkow discussed how employers are navigating coverage decisions and incorporating weight management programs like Verily Lightpath*
however, a substantial proportion of ...
Initiation of PERFORMA Phase 3 MASH trial planned for second half 2026 $535 million in cash, cash equivalents and short-term investments as of April 30, 2026 Webcast to be held today at 8:30 a.m
PlexusDx explains practical post-injection hygiene guidelines to optimize your treatment experience
There is, however, controversy regarding expression of GLP1 receptors (GLP1R) in human normal and diseased thyroid and pancreas
